Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kintor Pharmaceutical Ltd ( (HK:9939) ) has shared an announcement.
Kintor Pharmaceutical Limited has entered into a brand and sales operation cooperation agreement with Hangzhou ToMax Co., Ltd. to enhance the overseas market presence of its cosmetic products. This strategic partnership aims to leverage Kintor’s expertise in research, development, and manufacturing with ToMax’s marketing and promotional capabilities, thereby expanding the reach and sales of Kintor’s cosmetics globally. The collaboration is expected to result in mutual benefits and a win-win outcome for both parties, strengthening Kintor’s position in the cosmetics industry.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited, incorporated in the Cayman Islands, operates in the pharmaceutical industry with a focus on developing and commercializing innovative therapies. The company is expanding its market presence by venturing into the cosmetics sector, offering products such as anti-hair loss, acne treatment, and skin whitening solutions.
YTD Price Performance: 18.56%
Average Trading Volume: 1,269,324
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$506.3M
For an in-depth examination of 9939 stock, go to TipRanks’ Stock Analysis page.